Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06818214

Mechanistic Study on the Diagnosis of Esophageal Cancer Lymph Node Metastasis Using Spectral CT, Multimodal MRI, FAPI PET-CT, Pathology, and AI Evaluation System

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Henan Cancer Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to address the urgent issues in the diagnosis of lymph node metastasis in esophageal cancer. By employing multimodal MRI, spectral CT imaging and FAPI PET-CTtechniques, the study will correlate lymph node images with postoperative pathology results. Additionally, AI technology will be applied to learn from multimodal imaging data, enabling comprehensive analysis and evaluation of lymph node metastasis. Using a large volume of clinical and imaging data, a predictive model will be established to provide individualized lymph node metastasis risk assessments for each esophageal cancer patient. This will, in turn, offer robust support for personalized treatment strategies in esophageal cancer.

Conditions

Timeline

Start date
2025-02-01
Primary completion
2030-01-01
Completion
2030-12-01
First posted
2025-02-10
Last updated
2025-02-10

Source: ClinicalTrials.gov record NCT06818214. Inclusion in this directory is not an endorsement.